Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).
Immediately contact the Department of Health at 808-586-4586. Symptoms may include fever, cough, sore throat and conjunctivitis. It’s recommended to receive antiviral flu treatment as soon as possible ...